IMDX Competitors & Alternatives
Compare Insight Molecular Diagnostics Inc. with similar stocks in the same industry
Diagnostics & Research
IMDX
Main Stock$3.47
Tradestie Score
48
Market Cap
$94.16M
Revenue Growth
-0.5%
Analyst Upside
+137.8%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$17.78
|
$1.13B | - | 33 | Compare |
|
CDNA
CareDx, Inc.
|
$66.23
|
$798.40M | 31.1 | 32 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$21.30
|
$719.31M | - | 48 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$35.26
|
$667.77M | - | 43 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$16.17
|
$612.76M | - | 62 | Compare |
|
LCTX
Lineage Cell Therapeutics, Inc.
|
$0.90
|
$385.92M | - | 58 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$31.85
|
$62.81M | - | 59 | Compare |
|
AKTX
Akari Therapeutics plc ADR (0.01 USD)
|
$8.84
|
$31.97M | - | 43 | Compare |
|
SYBX
Synlogic, Inc. Common Stock
|
$0.56
|
$19.89M | - | 42 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$2.24
|
$4.78M | - | 58 | Compare |
More IMDX Analysis
Data updated: Oct 01, 2026 | Industry: Diagnostics & Research (SIC 2835)
39 stocks in this industry